QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT00626106. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An International, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Study identification
- NCT ID
- NCT00626106
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NantCell, Inc.
- Industry
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- AMG 479 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 26, 2008
- Primary completion
- May 4, 2010
- Completion
- Sep 22, 2011
- Last update posted
- Sep 18, 2024
2008 – 2011
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Chandler | Arizona | 85224 | — |
| Research Site | Anaheim | California | 92801 | — |
| Research Site | Beverly Hills | California | 90211 | — |
| Research Site | Concord | California | 94520 | — |
| Research Site | Duarte | California | 91010 | — |
| Research Site | Montebello | California | 90640 | — |
| Research Site | San Francisco | California | 94115 | — |
| Research Site | Sylmar | California | 91342 | — |
| Research Site | Stamford | Connecticut | 06902 | — |
| Research Site | Boca Raton | Florida | 33428 | — |
| Research Site | Boynton Beach | Florida | 33435 | — |
| Research Site | Coral Springs | Florida | 33065 | — |
| Research Site | Gainesville | Florida | 32605 | — |
| Research Site | Lake Worth | Florida | 33467 | — |
| Research Site | Atlanta | Georgia | 30309 | — |
| Research Site | Marietta | Georgia | 30060 | — |
| Research Site | Chicago | Illinois | 60637 | — |
| Research Site | Lebanon | New Hampshire | 03756 | — |
| Research Site | Denville | New Jersey | 07834 | — |
| Research Site | High Point | North Carolina | 27262 | — |
| Research Site | Hershey | Pennsylvania | 17033 | — |
| Research Site | Pittsburgh | Pennsylvania | 15213 | — |
| Research Site | Memphis | Tennessee | 38120 | — |
| Research Site | American Fork | Utah | 84003 | — |
| Research Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00626106, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00626106 live on ClinicalTrials.gov.